Industry / Bolivia
Bayer Launches Drugs To Target Cardiovascular Diseases
February 2012 | Industry Trend AnalysisBMI View: Bolivia's pharmaceutical market will experience relatively strong growth due to the country's economic development and strong demand for affordable and authentic generic drugs. Multinational drugmakers will target the higher-margin component of the market to meet the increasing demand for branded medicines among middle class
To read the full article, please choose one of the following options:
Subcribers please log in




